The male fertility research group at The University of Dundee is further expanding. We have recently been awarded a Bill and Melinda Gates Foundation Phase 2 Grand Challenges Explorations award for ‘Male Contraceptive Drug Development using a Novel Sperm Phenotypic Screening Platform’. We are seeking to appoint at least 2 highly motivated post-doctoral scientists to join our team.

This work will involve collaboration between the School of Medicine and School of Life Sciences (National Phenotypic Screening Centre; http://drugdiscovery.dundee.ac.uk) which has produced a stream of high quality papers in translational reproductive medicine in the last 3-4 years.

We will be placing formal adverts over the coming months but if you are interested in working with us please contact us with your CV and experience.

Professor C Barratt   c.barratt@dundee.ac.uk